Company Information
CIN
Status
Date of Incorporation
06 October 1997
State / ROC
Hyderabad / ROC Hyderabad
Last Balance Sheet
31 March 2023
Last Annual Meeting
30 September 2023
Paid Up Capital
15,009,090
Authorised Capital
76,500,000
Directors
Anil Jain .
Director/Designated Partner
over 2 years ago
over 2 years ago
Vijaykumar Raghunandanprasad Agrawal
Director/Designated Partner
over 2 years ago
over 2 years ago
Venkata Reddy Alla
Director/Designated Partner
almost 3 years ago
almost 3 years ago
Santosh Babu Busani
Director/Designated Partner
about 4 years ago
about 4 years ago
Yogeswara Rao Danda
Director
over 10 years ago
over 10 years ago
Alla Ratna Kumari
Director/Designated Partner
over 18 years ago
over 18 years ago
Past Directors
Vishakha Bhupendra Dhablia
Additional Director
over 7 years ago
over 7 years ago
Francisco Javier Castellsague Casals
Director
about 18 years ago
about 18 years ago
Gary Ethan Kamins
Director
about 18 years ago
about 18 years ago
Raghumitra Alla
Director
over 19 years ago
over 19 years ago
Dr Gopala Rao Tatineni
Director
over 26 years ago
over 26 years ago
Patents
Abstract Of The Invention
The present invention relates to a novel and improved process for the preparation of Sitagliptin of Formula I and its pharmaceutically acceptable salts.
The present invention also relates to novel intermediates and process for the preparation of intermediates used in the preparation o...
The present invention relates to oxazolidinone antibacterial agent anhydrous Linezolid crystalline form-II.
The present invention relates to a new process for preparing the
oxazolidinone antibacterial agent Linezolid including key intermediates of
oxazolidinones, which comprises the following reactions.
Step (a): Reacting 3-fluoro-4-morpholinyl aniline with R-epichlorohydrin
Step (b): Carbonylation to form oxazolidino...
The invention relates to a novel process for preparation of crystalline Linezolid Form-III. The crystalline Linezolid Form-III obtained by the process is highly pure with HPLC purity equal to or greater than 99.9% with single un-known impurity less than 0.05%.
NOVEL OXAZOLIDINONE COMPOUNDS
A novel oxazolidinone compound (S)-N-((3-(4-fluoro-3-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide of formula –I and a process for the preparation thereof.
Compound-I
A commercially viable process for industrial preparation of [(S)-n-tert butoxycarbonyl-3-hydroxy]adamantylglycine which is a key intermediate for saxagliptin synthesis and is represented by compound of Formula-VI. The compound-VI obtained by the process of present invention has more than 99.5% HPLC purity not more ...
The invention relates to the process of obtaining novel polymorphic form of Voriconazole. Voriconazole has the chemical name (2R, 3S)-2-(2,4-difluorophenYl)-3-(5-fluoropyrimidin-4-yl)-l-(lH-l,2,4-triazol-yl)-butan-2-ol represented as Formula (I)
To,
Controller of Patents Patent Office Branch IPR Building, GST R...
Disclosed herein is a cost effective and industrially feasible process for the preparation of clopidogrel bisulphate. The present invention further discloses a novel method of precipitation of clopidogrel bisulphate form 1 directly from solvent mix of methanol and acetone in presence of sulfuric acid at a temperatu...
An improved method for the synthesis of omeprazole form A, comprising the steps of reacting 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-1H-benzimidazole in methanol with hydrogen peroxide in presence of a mixture of ammonium molybdate and ammonium dihydrogen ortho phosphate, resulting in crude form...
The present invention provides a process for the preparation of substituted 2-(2-pyridylmethyl) sulphinyl-1H-benzimidazoles a compound comprising the steps of
a) thio compound is oxidized with an oxidizing agent in presence of alcohol,
b) extraction and followed by an isolation in halogenated hydrocarbon,
c) f...
Disclosed herein is process for preparation of crystalline form of (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-lH-benzimidazolemagnesium dihydrate which comprises: dissolving (S)-Omepra2ole potassium in dimethyl formamide; reacting with magnesium chloride hexa hydrate; removing the salts ...
A commercially viable process for industrial preparation of trans-(1R,2R)-cyclohexane 1,2–dicarboxylic acid represented by compound of Formula-I, wherein the compound has more than 99% HPLC purity. The compound of Formula-I is a key intermediate in preparation of Lurasidone hydrochloride which is a well known antips...
A novel oxazolidinone antibacterial compound [(S)- N- [[3-[4-fluoro-3-morpholino phenyl]-2-oxooxazolidin-5-yl] methyl] acetamide] of Formula-I and its broad spectrum antibacterial activities against a large number of gram positive and gram negative pathogens is disclosed.
Compound-I
ABSTRACT
The present invention relates to stable amorphous form of pharmaceutically acceptable salt of a dipeptidyl peptidase-4 (dpp-4) enzyme inhibitor. The present invention specifically relates to stable amorphous form of pharmaceutically acceptable salts of Sitagliptin. The present invention more specifically r...
ABSTRACT
NOVEL PROCESS FOR PREPARATION OF ANTIHISTAMINE AGENT INTERMEDIATES AND USES THEREOF
The present invention relates to novel process for the preparation of intermediate compounds used in the preparation of Antihistamine agents. The present invention particularly relates to novel process for the preparation ...
Stable Amorphous Form Of Potassium –Competitive Acid Blocker And Process For The Preparation Thereof
ABSTRACT
STABLE AMORPHOUS FORM OF POTASSIUM –COMPETITIVE ACID BLOCKER AND PROCESS FOR THE PREPARATION THEREO
The present invention provides a stable amorphous Tegoprazan of the formula (I). The present invention provides stable amorphous Tegoprazan free from other solid state forms and stable over shelf life and...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF GABAPENTINOID
The present invention relates to an improved process for the preparation of compound, 2-((1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3-en-6-yl)acetic acid used in the preparation of Mirogabalin Besylate. The present invention specificall...
ABSTRACT
AN IMPROVED PROCESS FOR THE ENANTIOSELECTIVE PREPARATION OF FINERENONE INTERMEDIATE COMPOUND
The present invention relates to an improved process for the enantioselective Finerenone intermediate compound of Formula (I) used in the preparation of Finerenone. The present invention specifically relates t...
ABSTRACT
AN IMPROVED PROCESS FOR THE PREPARATION OF RESMETIROM FORM I
The present invention relates to an improved process for the preparation of Resmetirom Crystalline Form I. The present invention relates to an improved process for the preparation of Resmetirom Crystalline Form I free from other solid state form...
Registered Trademarks
[Class : 5] Pharmaceutical & Medicinal Preparations; Dietetic Substances Adapted For Medical Use
[Class : 5] Pharmaceutical & Medicinal Preparations; Dietetic Substances Adapted For Medical Use
[Class : 5] Pharmaceutical & Medicinal Preparations; Dietetic Substances Adapted For Medical Use
View +60 more Brands for Lee Pharma Limited.
Charges
31 October 2019
Profectus Capital Private Limited
45 Lak
29 September 2019
Profectus Capital Private Limited
34 Lak
01 July 2019
Syndicate Bank
3 Crore
30 November 2018
Tata Capital Financial Services Limited
3 Crore
18 August 2018
Svc Co-operative Bank Ltd
29 Crore
30 December 2017
Reliance Commercial Finance Limited
2 Crore
27 June 2017
Axis Bank Limited
5 Lak
27 May 2017
Tata Capital Financial Services Limited
1 Crore
26 August 2016
Edelweiss Retail Finance Limited
2 Crore
31 December 2014
State Bank Of India
92 Crore
25 July 2014
Hdfc Bank Limited
15 Crore
30 January 2014
Sbi Global Factors Limited
22 Crore
01 March 1999
State Bank Of India
75 Crore
01 March 1999
State Bank Of India
52 Lak
15 September 2014
Electronica Finance Limited
1 Crore
25 November 2015
Electronica Finance Limited
1 Crore
30 May 2014
Reliance Capital Ltd
52 Lak
22 November 2013
Reliance Capital Ltd
57 Lak
30 June 2013
Reliance Capital Ltd
55 Lak
30 April 2012
Reliance Capital Ltd
43 Lak
26 February 2013
Reliance Capital Ltd
57 Lak
18 February 2021
Svc Co-operative Bank Ltd
15 Crore
18 September 2020
State Bank Of India
25 Crore
29 July 2020
Bajaj Finance Limited
18 Crore
02 July 2020
Profectus Capital Private Limited
62 Lak
27 December 2019
Profectus Capital Private Limited
1 Crore
29 July 2020
Canara Bank
2 Crore
24 October 2023
State Bank Of India
0
19 May 2023
Others
0
19 May 2023
Others
0
27 March 2023
Others
0
23 March 2023
Hdfc Bank Limited
0
29 December 2022
Sbicap Trustee Company Limited
0
04 October 2022
State Bank Of India
0
27 May 2017
Tata Capital Financial Services Limited
0
11 May 2022
Canara Bank
0
30 November 2018
Tata Capital Financial Services Limited
0
11 May 2022
Canara Bank
0
27 December 2019
Others
0
21 February 2022
Others
0
30 December 2021
State Bank Of India
0
31 January 2022
State Bank Of India
0
31 October 2019
Others
0
26 August 2016
Others
0
25 November 2021
Canara Bank
0
29 September 2019
Others
0
18 February 2021
Others
0
29 July 2020
Others
0
18 September 2020
State Bank Of India
0
02 July 2020
Others
0
01 July 2019
Syndicate Bank
0
18 August 2018
Others
0
27 June 2017
Others
0
29 July 2020
Canara Bank
0
31 December 2014
State Bank Of India
0
30 January 2014
Others
0
30 December 2017
Others
0
22 November 2013
Reliance Capital Ltd
0
01 March 1999
State Bank Of India
0
26 February 2013
Reliance Capital Ltd
0
30 May 2014
Reliance Capital Ltd
0
01 March 1999
State Bank Of India
0
25 July 2014
Hdfc Bank Limited
0
30 April 2012
Reliance Capital Ltd
0
25 November 2015
Electronica Finance Limited
0
30 June 2013
Reliance Capital Ltd
0
15 September 2014
Electronica Finance Limited
0
24 October 2023
State Bank Of India
0
19 May 2023
Others
0
19 May 2023
Others
0
27 March 2023
Others
0
23 March 2023
Hdfc Bank Limited
0
29 December 2022
Sbicap Trustee Company Limited
0
04 October 2022
State Bank Of India
0
27 May 2017
Tata Capital Financial Services Limited
0
11 May 2022
Canara Bank
0
30 November 2018
Tata Capital Financial Services Limited
0
11 May 2022
Canara Bank
0
27 December 2019
Others
0
21 February 2022
Others
0
30 December 2021
State Bank Of India
0
31 January 2022
State Bank Of India
0
31 October 2019
Others
0
26 August 2016
Others
0
25 November 2021
Canara Bank
0
29 September 2019
Others
0
18 February 2021
Others
0
29 July 2020
Others
0
18 September 2020
State Bank Of India
0
02 July 2020
Others
0
01 July 2019
Syndicate Bank
0
18 August 2018
Others
0
27 June 2017
Others
0
29 July 2020
Canara Bank
0
31 December 2014
State Bank Of India
0
30 January 2014
Others
0
30 December 2017
Others
0
22 November 2013
Reliance Capital Ltd
0
01 March 1999
State Bank Of India
0
26 February 2013
Reliance Capital Ltd
0
30 May 2014
Reliance Capital Ltd
0
01 March 1999
State Bank Of India
0
25 July 2014
Hdfc Bank Limited
0
30 April 2012
Reliance Capital Ltd
0
25 November 2015
Electronica Finance Limited
0
30 June 2013
Reliance Capital Ltd
0
15 September 2014
Electronica Finance Limited
0
